Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Analysis of pediatric clinical drug trials for neuropsychiatric conditions.

Murthy S, Mandl KD, Bourgeois F.

Pediatrics. 2013 Jun;131(6):1125-31. doi: 10.1542/peds.2012-2694. Epub 2013 May 6.

2.

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2013 Oct 25;62(RR-09):1-12. Erratum in: MMWR Recomm Rep. 2013 Nov 15;62(45):906.

3.

Pediatric uptake of a newly available antipsychotic medication.

Penfold RB, Kelleher KJ, Wang W, Strange B, Pajer K.

Pediatrics. 2010 Mar;125(3):475-82. doi: 10.1542/peds.2009-1288. Epub 2010 Feb 8.

PMID:
20142282
4.

The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Dunn AG, Mandl KD, Coiera E, Bourgeois FT.

PLoS One. 2013 Dec 23;8(12):e84951. doi: 10.1371/journal.pone.0084951. eCollection 2013.

5.

Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.

Borges AP, Campos MS, Pereira LR.

Int J Clin Pharm. 2013 Jun;35(3):425-31. doi: 10.1007/s11096-013-9755-2. Epub 2013 Feb 21.

PMID:
23430533
6.
7.

[Survey on common pediatric drugs for renal diseases].

Ye WQ, Liang Y, Cui YM, Ding J.

Zhonghua Er Ke Za Zhi. 2013 Dec;51(12):888-91. Chinese.

PMID:
24495757
8.
9.

Association between pediatric clinical trials and global burden of disease.

Bourgeois FT, Olson KL, Ioannidis JP, Mandl KD.

Pediatrics. 2014 Jan;133(1):78-87. doi: 10.1542/peds.2013-2567. Epub 2013 Dec 16.

10.

Pediatric versus adult drug trials for conditions with high pediatric disease burden.

Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JP, Mandl KD.

Pediatrics. 2012 Aug;130(2):285-92. doi: 10.1542/peds.2012-0139. Epub 2012 Jul 23.

11.

Publication of clinical trials supporting successful new drug applications: a literature analysis.

Lee K, Bacchetti P, Sim I.

PLoS Med. 2008 Sep 23;5(9):e191. doi: 10.1371/journal.pmed.0050191.

12.

A new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves.

Yoganathan AP, Fogel M, Gamble S, Morton M, Schmidt P, Secunda J, Vidmar S, Del Nido P.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):879-86. doi: 10.1016/j.jtcvs.2013.04.016. Epub 2013 Jun 21.

PMID:
23796593
13.

IOM Review of FDA--approved biologics labeled or studied for pediatric use.

Field MJ, Ellinger LK, Boat TF.

Pediatrics. 2013 Feb;131(2):328-35. doi: 10.1542/peds.2012-2412. Epub 2013 Jan 14. Review.

14.

[Off-label use of psychotropic medications in pediatric wards: a prospective study].

Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O.

Arch Pediatr. 2009 Sep;16(9):1252-60. doi: 10.1016/j.arcped.2009.06.012. Epub 2009 Jul 28. French.

PMID:
19640689
15.

Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects.

Cummings JL, Jeste DV.

Psychopharmacol Bull. 2007;40(4):89-98. Review.

PMID:
18227780
16.

Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.

Czaja AS, Valuck R.

Pharmacoepidemiol Drug Saf. 2012 Sep;21(9):997-1004. doi: 10.1002/pds.3312. Epub 2012 Jul 4.

PMID:
22760843
17.

Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.

Shimazawa R, Ikeda M.

Clin Ther. 2012 Oct;34(10):2104-16. doi: 10.1016/j.clinthera.2012.09.004. Epub 2012 Oct 2.

PMID:
23036337
18.

Pivotal studies of orphan drugs approved for neurological diseases.

Mitsumoto J, Dorsey ER, Beck CA, Kieburtz K, Griggs RC.

Ann Neurol. 2009 Aug;66(2):184-90. doi: 10.1002/ana.21676.

19.

Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.

DiMasi JA.

Clin Ther. 2013 Jun;35(6):808-18. doi: 10.1016/j.clinthera.2013.04.004. Epub 2013 May 28.

PMID:
23726388
20.

Unlicensed and off-label prescription of respiratory drugs to children.

't Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Strickerf BH.

Eur Respir J. 2004 Feb;23(2):310-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk